|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1814 News |
|
| «12...20212223242526272829303132 |
- FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Cigarette Smoke and Susceptibility to Influenza Infection (clinicaltrials.gov) - Oct 4, 2011
P=N/A, N=135, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed
- Enrollment change: Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study) (clinicaltrials.gov) - Oct 2, 2011
P=N/A, N=1200, Recruiting, Sponsor: University of Tennessee
Active, not recruiting --> Completed N=2158 --> 1200
- | Chantix (varenicline) / Pfizer
New P2 trial, Combination therapy: Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation (clinicaltrials.gov) - Sep 28, 2011
P2, N=446, Completed, Sponsor: University of Stellenbosch
- ||||| New P2 trial: Meclizine as a Potential Smoking Cessation Treatment (clinicaltrials.gov) - Sep 28, 2011
P2, N=146, Completed, Sponsor: Duke University
- ||| Clinical: A Study on the Effects of Two Nicotine Replacement Products on Tooth Staining (clinicaltrials.gov) - Sep 25, 2011
P=N/A, N=200, Completed, Sponsor: McNeil AB
- || Enrollment change, Metastases: Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients (clinicaltrials.gov) - Sep 25, 2011
P=N/A, N=186, Completed, Sponsor: AstraZeneca
N=2158 --> 1200 N=300 --> 186
- ||| Trial completion, Metastases: Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients (clinicaltrials.gov) - Sep 25, 2011
P=N/A, N=186, Completed, Sponsor: AstraZeneca
N=300 --> 186 Recruiting --> Completed
- Enrollment open: Cognitive Training for Nicotine Dependence (clinicaltrials.gov) - Sep 20, 2011
P=N/A, N=200, Recruiting, Sponsor: University of Pennsylvania
Recruiting --> Completed Not yet recruiting --> Recruiting
- New P1 trial: Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction (clinicaltrials.gov) - Sep 20, 2011
P1, N=60, Recruiting, Sponsor: The Queen Elizabeth Hospital
- bupropion sustained-release / Generic mfg.
Enrollment closed, Real-world evidence, Real-world effectiveness, Real-world: STOP Study: Effectiveness of Zyban in a Clinical Population (clinicaltrials.gov) - Sep 12, 2011
P4, N=750, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: Functional Assessment Screening Tablets - Patient Reported Measures (clinicaltrials.gov) - Sep 11, 2011
P=N/A, N=150, Completed, Sponsor: University of Pittsburgh
Recruiting --> Active, not recruiting Enrolling by invitation --> Completed
- Trial completion: Smoking Cessation and Sexual Health in Men (clinicaltrials.gov) - Sep 8, 2011
P1, N=80, Completed, Sponsor: University of Texas at Austin
Enrolling by invitation --> Completed Recruiting --> Completed
- ||| New P1 trial: Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke (clinicaltrials.gov) - Aug 31, 2011
P1, N=109, Completed, Sponsor: Rock Creek Pharmaceuticals, Inc.
- New P3 trial: Brain Nicotine Receptor Density & Response to Nicotine Patch (clinicaltrials.gov) - Aug 28, 2011
P3, N=50, Not yet recruiting, Sponsor: Brentwood Biomedical Research Institute
- Enrollment closed: Lung Inflammation and Lung Metastases From Breast Cancer (clinicaltrials.gov) - Aug 21, 2011
P=N/A, N=400, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| Trial completion: Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation (clinicaltrials.gov) - Aug 18, 2011
P3, N=723, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| Trial completion: Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation (clinicaltrials.gov) - Aug 18, 2011
P=N/A, N=169, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy (clinicaltrials.gov) - Aug 17, 2011
P2, N=76, Active, not recruiting, Sponsor: Yale University
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: School Nurse-Delivered Smoking Cessation Intervention (clinicaltrials.gov) - Aug 17, 2011
P2/3, N=1058, Completed, Sponsor: University of Massachusetts, Worcester
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- naltrexone / Generic mfg.
Trial completion: Efficacy of Naltrexone in Women's Smoking Cessation (clinicaltrials.gov) - Aug 9, 2011
P2, N=333, Completed, Sponsor: University of Chicago
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Chantix (varenicline) / Pfizer
New P2 trial: Varenicline In-Patient Study (clinicaltrials.gov) - Aug 8, 2011
P2, N=80, Recruiting, Sponsor: Stanford University